These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19562769)

  • 1. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.
    Lee JY; Lee EK; Park SS; Lim JY; Kim HJ; Kim JS; Jeon BS
    Mov Disord; 2009 Sep; 24(12):1803-10. PubMed ID: 19562769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
    Krishnamoorthy S; Rajan R; Banerjee M; Kumar H; Sarma G; Krishnan S; Sarma S; Kishore A
    Parkinsonism Relat Disord; 2016 Sep; 30():13-7. PubMed ID: 27325396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.
    Lee JY; Cho J; Lee EK; Park SS; Jeon BS
    Mov Disord; 2011 Jan; 26(1):73-9. PubMed ID: 20945430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients.
    Zainal Abidin S; Tan EL; Chan SC; Jaafar A; Lee AX; Abd Hamid MH; Abdul Murad NA; Pakarul Razy NF; Azmin S; Ahmad Annuar A; Lim SY; Cheah PS; Ling KH; Mohamed Ibrahim N
    BMC Neurol; 2015 Apr; 15():59. PubMed ID: 25896831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
    Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
    Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
    Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
    Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
    Kraemmer J; Smith K; Weintraub D; Guillemot V; Nalls MA; Cormier-Dequaire F; Moszer I; Brice A; Singleton AB; Corvol JC
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1106-11. PubMed ID: 27076492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.
    Hassan A; Heckman MG; Ahlskog JE; Wszolek ZK; Serie DJ; Uitti RJ; van Gerpen JA; Okun MS; Rayaprolu S; Ross OA
    Parkinsonism Relat Disord; 2016 Jan; 22():102-5. PubMed ID: 26627941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
    Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
    Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease.
    Lee JY; Kim JM; Kim JW; Cho J; Lee WY; Kim HJ; Jeon BS
    Parkinsonism Relat Disord; 2010 Mar; 16(3):202-7. PubMed ID: 20018549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of impulse control disorders in Parkinson's disease.
    Cormier F; Muellner J; Corvol JC
    J Neural Transm (Vienna); 2013 Apr; 120(4):665-71. PubMed ID: 23232665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
    McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
    J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the DRD2 CA
    Xu S; Liu J; Yang X; Qian Y; Xiao Q
    J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation.
    Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N
    J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulsive compulsive behaviors in Japanese Parkinson's disease patients and utility of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease.
    Tanaka K; Wada-Isoe K; Nakashita S; Yamamoto M; Nakashima K
    J Neurol Sci; 2013 Aug; 331(1-2):76-80. PubMed ID: 23735774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.
    Kim J; Kim M; Kwon DY; Seo WK; Kim JH; Baik JS; Koh SB
    J Neurol; 2013 Feb; 260(2):429-37. PubMed ID: 22893307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
    Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J
    Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.
    Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH
    Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.